Works matching IS 13866346 AND DT 2022 AND VI 52 AND IP 2


Results: 9
    1
    2

    Development and multicenter validation of FIB‐6: A novel, machine learning, simple bedside score to rule out liver cirrhosis and compensated advanced chronic liver disease in patients with chronic hepatitis C.

    Published in:
    Hepatology Research, 2022, v. 52, n. 2, p. 165, doi. 10.1111/hepr.13729
    By:
    • Shiha, Gamal;
    • Soliman, Reham;
    • Mikhail, Nabiel N. H.;
    • Alswat, Khalid;
    • Abdo, Ayman;
    • Sanai, Faisal;
    • Derbala, Moutaz F.;
    • Örmeci, Necati;
    • Dalekos, George N.;
    • Al‐Busafi, Said;
    • Hamoudi, Waseem;
    • Sharara, Ala I.;
    • Zaky, Samy;
    • El‐Raey, Fathiya;
    • Mabrouk, Mai;
    • Marzouk, Samir;
    • Toyoda, Hidenori
    Publication type:
    Article
    3
    4
    5

    Renal safety and biochemical changes for 2 years after switching to tenofovir alafenamide from long‐term other nucleotide analog treatment in patients with chronic hepatitis B.

    Published in:
    Hepatology Research, 2022, v. 52, n. 2, p. 153, doi. 10.1111/hepr.13726
    By:
    • Hosaka, Tetsuya;
    • Suzuki, Fumitaka;
    • Kobayashi, Masahiro;
    • Fujiyama, Shunichirou;
    • Kawamura, Yusuke;
    • Sezaki, Hitomi;
    • Akuta, Norio;
    • Suzuki, Yoshiyuki;
    • Saitoh, Satoshi;
    • Arase, Yasuji;
    • Ikeda, Kenji;
    • Kobayashi, Mariko;
    • Kumada, Hiromitsu
    Publication type:
    Article
    6
    7
    8
    9

    Issue Information.

    Published in:
    Hepatology Research, 2022, v. 52, n. 2, p. 137, doi. 10.1111/hepr.13653
    Publication type:
    Article